Hubert Czerniak - Causes of Diseases in Children and Adults! This film is a must-see for everyone...

Czerniak builds the case that magnesium and zinc are not merely nutritional co‑factors but direct pharmacological tools. He references the classic physiology that magnesium blocks the NMDA pore in a voltage‑dependent manner and that zinc acts at a distinct allosteric site. Because mercury and aluminum displace these metals from their binding sites—mercury being a million times more reactive with thiol groups—the receptor loses its endogenous brakes. Replenishing both minerals in excess can competitively re‑occupy those sites and dampen the hypersensitive state. He does not specify a brand but suggests a strongly hygroscopic (moisture‑attracting) formulation, possibly to improve absorption or bioavailability. The protocol is meant to be combined with metal removal strategies, as magnesium and zinc alone will not extract the offending metals.

Lugol’s iodine is a classic antiseptic and nutritional supplement, but in alternative medical circles it is used as a systemic detoxifier. Czerniak introduces it after describing how heavy metals are excreted into the intestinal lumen; he worries that without a binder, they will be reabsorbed in the colon. Iodine is thus paired with intestinal binders to create a ‘push‑pull’ elimination. He notes that high doses may overwhelm the system, evidenced by an acneiform eruption, which he interprets not as toxicity but as a sign of rapid mobilization—hence the advice to reduce rather than discontinue. The protocol is entirely empirical and would be considered dangerous by mainstream toxicology because pushing metal excretion without tight monitoring can cause acute redistribution and organ damage.

After explaining that the body will try to dump heavy metals into the gut, Czerniak insists that a ‘sponge’ is necessary to stop enterohepatic recirculation. He lists several options without preference, treating them as interchangeable. This is a standard naturopathic approach to detoxification. He gives no laboratory evidence or brand names, simply naming natural substances that are widely available as powders or supplements. The guidance is purely pragmatic: take them with water, and combine with sweating (exercise) and salt water to drive the elimination through multiple routes.

Czerniak emphatically repeats that children “have to run, run, run and sweat.” He couples this with the instruction to give them Kłodawa salt—a traditional Polish rock salt—dissolved in water. The sweating protocol is positioned as a simple, cost‑free adjunct to binders and iodine, ensuring that metals not trapped in the gut can leave through the skin. He mentions cadmium specifically as a metal best eliminated via sweat (“kadm najlepiej spotem”). This reflects a folk‑medicine belief that profuse sweating purifies the blood, here given a scientific veneer by associating it with heavy‑metal toxicokinetics.

The speaker uses the NMDA receptor diagram to illustrate multiple intervention points. Having already discussed GABA (site not shown but described as opposing NMDA), magnesium (channel pore), zinc (site five), he turns to site four, which he calls the ‘hallucinogen binding site.’ He notes that cannabinoids like CBD and CBG can attenuate the over‑responsiveness of NMDA receptors, which explains why these substances calm epileptic seizures, reduce aggression in autistics, quiet tics, and even improve memory—a counterintuitive claim since cannabis is often linked to memory impairment. The unifying logic is that by tempering NMDA‑driven long‑term potentiation gone awry, the brain’s normal plasticity can resume. He cites Dravet syndrome as a classic example of a drug‑resistant epilepsy that responds to cannabinoids, consistent with the modern use of Epidiolex (FDA‑approved CBD) for Dravet and Lennox‑Gastaut syndromes.

Czerniak links the ubiquity of aspartame (1 kg replaces 10 tons of sugar) to a corporate motive for ignoring brain‑cancer and neurotoxicity concerns. He claims that scientists worldwide raised alarms about aspartame causing brain tumors, but Coca‑Cola and other companies blocked proper investigation. He extends the argument to other NMDA agonists like homocysteic acid and kainates, implying that the modern diet saturated with excitotoxic amino acids acts as a second hit on top of the heavy‑metal first hit, driving the childhood neurological epidemic. His solution is not modulation but complete avoidance, a low‑hanging fruit that every parent can enact immediately.

Czerniak opens by describing the unique anatomy of the blood‑brain barrier: tight‑junctioned endothelial cells, no direct contact between endothelia and neurons, and mandatory relay through astrocytes—cells that also shape synaptic plasticity and long‑term memory in the hippocampus. He argues that because the barrier is not sealed, any substance that enters the infant brain bypasses the adult‑grade filter. This, he says, explains why low doses of ethylmercury from vaccines (thimerosal) can produce staggered developmental delays—opóźniony rozwój at two months, tics at three months, attention deficit at six months—as documented in documents leaked from the Simpsonwood meeting. The implication is that the entire pediatric vaccine schedule from 0–6 months (and even up to 4 years) is administered during the window of maximal neuronal vulnerability, a design flaw that he believes underlies the modern explosion of ADHD, autism, and early epilepsies.

According to Czerniak, the 2000 meeting at Simpsonwood gathered the producers of ‘certain chemicals’ (thimerosal) who reviewed epidemiological data on infant neurodevelopment. The data showed a clear temporal sequence: two months after exposure—delayed development; three months—nervous tics; six months—attention deficit, followed by a spectrum of neurological impairments. He emphasizes that this information did not reach the public or wider scientific community until a decade later, thanks to leaks. He frames this as a deliberate cover‑up by corporations that profit from aspartame and vaccine preservatives, arguing that business interests (e.g., 1 kg aspartame providing the sweetness of 10 tons of sugar) outweigh children’s brain health.

Czerniak walks through the animation frame‑by‑frame: three developing neurons with central cell bodies, neurites tipped by actin‑based growth cones exhibiting pulsatile movement, and microtubules (built from orange‑colored tubulin) forming a ring around the neurofilament. When mercury is introduced for only 20 minutes, the growth cone degenerates, leaving the neurofilament ends exposed like bare wires. He emphasizes that this effect could not be reproduced with lead, cadmium, or aluminum—mercury is uniquely devastating. He then asks the rhetorical question: if a naked wire is left in the brain, can an arriving electrical impulse trigger a burst of excitation—a seizure? This positions the bare neurofilament as the anatomical basis for Dravet syndrome and other infantile epilepsies.

Czerniak explains that NMDA receptors are concentrated in the cerebral cortex (thinking), hippocampus (memory), striatum (motor control), and amygdala (fear). When heavy metals accumulate locally, they sensitize or overstimulate these receptors, producing region‑specific symptoms: seizures if the motor cortex/striatum is hit, memory and learning problems if the hippocampus is involved, anxiety and panic if the amygdala is overloaded. He notes that GABA (gamma‑aminobutyric acid) normally inhibits NMDA receptors, which is why GABAergic drugs are first‑line for Dravet syndrome. However, he argues that simply boosting GABA is a stopgap; the real solution is to remove the metal that keeps NMDA receptors pathologically hypersensitive. He mentions that cannabinoids (CBD, CBG) bind to a separate site on the NMDA receptor (site four) and can also dampen the over‑excitation, explaining why they calm aggressive autistic children and reduce tics and improve memory—all via the same receptor system.